86 related articles for article (PubMed ID: 10624115)
1. Evaluation of DNA content and proliferative activity in prediction of short-term relapses in mammary carcinoma: a prospective study.
Lackowska B; Niezabitowski A; Ryś J; Skołyszewski J; Stelmach A; Sokołowski A; Gruchała A; Jaszcz-Gruchała A; Markiewicz D
Pol J Pathol; 1999; 50(3):139-44. PubMed ID: 10624115
[TBL] [Abstract][Full Text] [Related]
2. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
3. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
4. Hypoploidy defines patients with poor prognosis in breast cancer.
Chavez-Uribe E; Cameselle-Teijeiro J; Viñuela JE; Castro-Piñeiro C; Gude F; Forteza J; Puente-Domínguez JL
Oncol Rep; 2007 May; 17(5):1109-14. PubMed ID: 17390052
[TBL] [Abstract][Full Text] [Related]
5. S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.
Lackowska B; Niezabitowski A; Ryś J; Skołyszewski J; Stelmach A; Gruchała A; Jaszcz-Gruchała A
Pol J Pathol; 2003; 54(2):101-10. PubMed ID: 14575418
[TBL] [Abstract][Full Text] [Related]
6. Prognostic markers in node-negative breast cancer: a prospective study.
Kute TE; Russell GB; Zbieranski N; Long R; Johnston S; Williams H; Stackhouse C; Wilkins L; Evans I; Berry P; Rimmer K; Tucker E
Cytometry B Clin Cytom; 2004 May; 59(1):24-31. PubMed ID: 15108167
[TBL] [Abstract][Full Text] [Related]
7. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
[TBL] [Abstract][Full Text] [Related]
8. Prediction of relapse in patients with breast cancer by DNA cytometry.
Machado-Santelli GM; Mori L; Pereira CA
Anal Cell Pathol; 1994 Dec; 7(4):321-34. PubMed ID: 7696156
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometry in cervical adenocarcinoma. Correlating DNA content analysis with the clinical picture.
Kaspar HG; Dinh TV; Hannigan EV
J Reprod Med; 1997 Mar; 42(3):170-2. PubMed ID: 9109087
[TBL] [Abstract][Full Text] [Related]
11. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
12. Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content.
El-Naggar AK; Kemp BL; Sneige N; Hurr KG; Steck K; Tu ZN; Fritsche HA; Singletary SE; Balch CM
Clin Cancer Res; 1996 Feb; 2(2):419-26. PubMed ID: 9816186
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance.
Michels JJ; Duigou F; Marnay J; Henry-Amar M; Delozier T; Denoux Y; Chasle J
Cancer; 2003 Mar; 97(6):1376-86. PubMed ID: 12627500
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity in primary breast carcinomas is a salient prognostic factor.
Michels JJ; Marnay J; Delozier T; Denoux Y; Chasle J
Cancer; 2004 Feb; 100(3):455-64. PubMed ID: 14745860
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
[TBL] [Abstract][Full Text] [Related]
17. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
18. Relationship of histology, DNA-values and proliferative activity in unselected breast cancer patients (a preliminary study).
Niezabitowski A; Ryś J; Lackowska B; Dyba T; Stelmach A; Gruchała A; Wasilewska A; Szklarski W; Kruczak A; Swiatkiewicz I
Pol J Pathol; 1995; 46(1):23-8. PubMed ID: 7780693
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
Michels JJ; Marnay J; Plancoulaine B; Chasle J
Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]